Literature DB >> 30515607

Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.

Chanatip Metheetrairut1, Chanticha Chotigavanich2, Kanchana Amornpichetkul3, Phawin Keskool2, Sunun Ongard2, Choakchai Metheetrairut2.   

Abstract

PURPOSE: The majority of head and neck squamous cell carcinoma (HNSCC) cases in developing countries are associated with cigarette smoking and TP53 mutations. p53 is a transcription factor that activates downstream genes, including the hsa-miR-34a and hsa-miR-34b/c loci, to achieve cell-cycle arrest, senescence, and/or apoptosis. This study examined the differences in expression levels of miR-34 in HNSCC with or without TP53 mutations.
METHODS: We examined surgically resected tumor samples and normal adjacent tissues from HNSCC in oral cavity, larynx, and hypopharynx for TP53 mutations (exons 5-8) and miR-34 expression levels.
RESULTS: miR-34a, miR-34b, miR-34b*, and miR-34c are significantly up-regulated in tumors with wild-type TP53 genes (n = 23); while such up-regulation is not observed in tumors with mutant TP53 (n = 19). Although expression levels of miR-34-family miRNAs do not correlate with gender, age, or tumor staging, interestingly they are correlated with smoking status and tumor sites. miR-34b/b*/c are up-regulated in tumors from those who ever smoked or recently smoked (quit smoking less than 15 years ago); but such up-regulation was not seen in those who never smoked or quit smoking for at least 15 years. HNSCC of the oral cavity also up-regulated miR-34b/b*/c while no such overexpression was observed in HNSCC of the larynx and hypopharynx.
CONCLUSIONS: Surgically resected HNSCC samples with no TP53 mutations have elevated levels of miR-34a and miR-34b/b*/c, while those with TP53 mutations show no such up-regulation. miR-34b/b*/c expression is also correlated with smoking status and tumor sites.

Entities:  

Keywords:  HNSCC; Head and neck squamous cell carcinoma; MiR-34; MicroRNA; TP53

Mesh:

Substances:

Year:  2018        PMID: 30515607     DOI: 10.1007/s00405-018-5223-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  4 in total

Review 1.  Mir-34a: a regulatory hub with versatile functions that controls osteosarcoma networks.

Authors:  Zhimin Yang; Tang Liu; Xiaolei Ren; Mei Yang; Chao Tu; Zhihong Li
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

2.  MicroRNA‑34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel.

Authors:  Megumi Yanokura; Kouji Banno; Daisuke Aoki
Journal:  Int J Oncol       Date:  2020-09-23       Impact factor: 5.650

3.  Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.

Authors:  Xun Wu; Yi-Shing Lisa Cheng; Mathew Matthen; Angela Yoon; Gary K Schwartz; Shashi Bala; Alison M Taylor; Fatemeh Momen-Heravi
Journal:  J Exp Clin Cancer Res       Date:  2021-02-17

4.  Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.

Authors:  Gordana Supic; Debora Stefik; Nemanja Ivkovic; Ahmad Sami; Katarina Zeljic; Sasa Jovic; Ruzica Kozomara; Danilo Vojvodic; Srboljub Stosic
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.